Ivy Rx vs LifeMD
LifeMD costs $26 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Ivy Rx
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Ivy Rx →
LifeMD
Best for: bloodwork inside the monthly price rather than billed on top
Visit LifeMD →If you are choosing between Ivy Rx and LifeMD, the first difference is cost: LifeMD is $26 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. LifeMD leads our six-part score, 7.9 to 7.3.
Ivy Rx vs LifeMD price
LifeMD is the cheaper way in: $149 a month against $175 a month at Ivy Rx. That is $26 less each month (15% lower), or about $312 over a year of treatment.
Drug by drug: Semaglutide is cheaper at LifeMD ($149 a month vs $175 a month); tirzepatide is cheaper at Ivy Rx ($275 a month vs $349 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, Ivy Rx prices compounded injections, while LifeMD prices brand-name pens.
If you want the FDA-approved brand rather than a compounded version, LifeMD is the only one of the two with a brand-name price.
Where each one treats patients
Ivy Rx lists 50 states, and LifeMD lists 50 states.
They overlap in 50 states.
Pricing
Ivy Rx
Range up to $197/mo
Range up to $297/mo
LifeMD
First month $75, then $149/mo. Brand medication billed separately, or $0-$25/mo copay with commercial insurance.
Medication only; plus the $149/mo program fee.
Medication only (starting); plus the program fee. As low as $0-$25/mo with insurance.
Medication only; plus the $149/mo program fee.
What each price covers
Both prices cover the clinician visit.
Ivy Rx's price also covers the medication itself and shipping, which LifeMD does not claim.
LifeMD's price also covers lab work and coaching, which Ivy Rx does not claim.
Ivy Rx is silent on lab work and coaching.
LifeMD is silent on shipping.
That matters most for the drug: unless LifeMD confirms otherwise, budget for medication on top of its listed price.
Ivy Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
LifeMD
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
In the price
Coaching
In the price
Where each one scores higher
Overall, LifeMD scores 7.9 and Ivy Rx 7.3 out of 10.
Ivy Rx is stronger on user experience (8.0 vs 3.0), trust & safety (7.5 vs 6.0) and support (7.0 vs 5.5).
LifeMD is stronger on value (10.0 vs 3.0).
Effectiveness and accessibility are within half a point.
Ivy Rx
7.3/10
LifeMD
7.9/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Ivy Rx nor LifeMD has an FDA warning letter on record with us.
Features & Coverage
| Feature | Ivy Rx | LifeMD |
|---|---|---|
| Starting Price | $175/mo | ✓$149/mo |
| Features | ✓3 features | 0 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Ivy Rx
Ivy Rx is a telehealth seller running tiered compounded semaglutide and tirzepatide programs.
Read our full Ivy Rx review →About LifeMD
LifeMD is a publicly traded telehealth seller. It carries brand-name GLP-1 medications only.
Read our full LifeMD review →Pros & Cons
Ivy Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- We found no FDA warning letters issued to Ivy Rx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
LifeMD
What we like
- Semaglutide costs $149 a month, 85% below the $990 median for brand-name semaglutide across the sellers we compare
- Tirzepatide costs $349 a month, 72% below the $1249 median for brand-name tirzepatide across the sellers we compare
- The monthly price includes clinician visits, lab work and coaching
- Serves all 50 states
- We found no FDA warning letters issued to LifeMD
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Not included in the monthly price: medication
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
LifeMD wins this one, 7.9 to 7.3, above all for bloodwork inside the monthly price rather than billed on top. It also costs $26 less each month than Ivy Rx. Ivy Rx fits better if coverage in all 50 states, which most sellers will not confirm is your priority.
Choose Ivy Rx if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $175 a month.
Choose LifeMD if…
You want bloodwork inside the monthly price rather than billed on top and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Wellorithm
Compounded semaglutide at $247/month
From $247/mo
Get started →Willow
Seeing what it charges before you answer any medical questions
From $299/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Ivy Rx vs LifeMD: FAQ
Close alternatives to Ivy Rx and LifeMD
- Ivy Rx vs DudeMeds
- Ivy Rx vs Curve
- Ivy Rx vs FitFlow
- Ivy Rx vs Genesis Health
- LifeMD vs altRX
- LifeMD vs Gala
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.